Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week

Journal of Thoracic Oncology

Volumn 2, Issue 10, 2007, Pages 916-926

  Miyamoto, Tadaaki ^a   Baba, Masayuki ^a   Sugane, Toshio ^a   Nakajima, Mio ^a   Yashiro, Tomoyasu ^d   Kagei, Kennji ^a   Hirasawa, Naoki ^a   Sugawara, Toshiyuki ^c   Yamamoto, Naoyoshi ^b   Koto, Masashi ^c   Ezawa, Hidefumi ^a   Kadono, Kennoshuke ^e   Tsujii, Hirohiko ^a   Mizoe, Jun Etsu ^a   Yoshikawa, Kyosan ^a   Kandatsu, Susumu ^a   Fujisawa, Takehiko ^e  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b SAKURA NATIONAL HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d CHIBA UNIVERSITY   (Japan)

^e National Hospital Organization Kasumigaura Medical Center   (Japan)

Author keywords

Carbon ion beams; Four fractions; Heavy particles; Non small cell lung cancer; Stage I

Indexed keywords

CARBON;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; COURSE EVALUATION; FEMALE; FOLLOW UP; HUMAN; INOPERABLE CANCER; ION THERAPY; KAPLAN MEIER METHOD; LOG RANK TEST; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34848914838     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181560a68     Document Type: Article

References (36)

1. Sibley GS. Radiotherapy for patients with medically inoperable stage I non-small-cell lung cancer. Cancer 1998;82:433-438.
2. Jeremic B, Classen J, Bamberg M. Radiotherapy alone technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002;54:119-130.
3. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
4. Naruke T, Tsuchiya R, Kondo H, et al. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 2001;71:1759-1764.
5. Schild SE, Bogart JA. Innovation in the radiotherapy of non-small cell lung cancer. J Thorac Oncol 2006;1:85-92.
6. Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427-1431.
7. Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma. Cancer 2004;101:1623-1631.
8. Bush DA, Slater JD, Bonnet R, et al. Proton-beam radiotherapy for early stage lung cancer. Chest 1999;116:1313-1319.
9. Shioyama Y, Tokuuye K, Okumuma T, et al. Clinical evaluation of proton radiotherrapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2003;56:7-13.
10. Kanai T, Furusawa Y, Fukutsu K, et al. Irradiation of mixed beam and design of spread out Bragg peak for heavy-ion radiotherapy. Radiat Res 1997;147:78-85.
11. Hirao Y, Ogawa H, Yamada S, et al. Heavy ion synchrotron for medical use - HIMAC project at NIRS-JAPAN. Nucl Phys A 1992;538:541c-550c.
12. Kanai T, Endo M, Minohara S, et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys 1999;44:201-210.
13. Miyamoto T, Yamamoto N, Nishimura Y, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2003;66:127-140.
14. Miyamoto T, Baba M, Yamamoto N, et al. Curative treatment of stage I non-small cell lung cancer with carbon ion beams using a hypofractionated regimen. Int J Radiat Oncol Biol Phys 2007;67:750-758.
15. Endo M, Koyama-Ito H, Minohara S, et al. Hiplan - a heavy ion treatment planning system at HIMAC. J Jpn Soc Ther Radiol Oncol 1996;8:231-238.
16. Minohara S, Kanai T, Endo M, et al. Respiratory gated irradiation system for heavy-ion radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1097-1103.
17. Yasukawa T, Yamaguchi Y, Aoyagi H, et al. Diagnosis of hilar and mediastinal lymph node metastasis of lung cancer by positoron emission tomography using 11C- methionine. Jpn J Lung Cancer 1996;36:919-926.
18. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EOR TC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
19. Definition of Objective Response. In WHO Handbook for Reporting the Results of Cancer Treatment. Geneva, Switzerland: World Health Organization, 1979. Pp. 23-25. Offset publication no. 48.
20. Bentzen SM. Towards evidence based radiation oncology. improving the design, analysis, and reporting of clinical outcome studies in radiotherapy. Radiother Oncol 1998;46:5-18.
21. Ekberg L, Holmberg O, Wittgren L, et al. Application of ICRU report 50. How should margins be added to the clinical target volume when defining the planning target volume, as exemplified for lung cancer. ICRU News December 1997:4-9.
22. Koto M, Miyamoto T, Yamamoto N, et al. Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother Oncol 2004;71:147-156.
23. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975;70:283-293.
24. Kanai T, Matsufuji N, Miyamoto T, et al. Examination of GyE system for HIMAC carbon therapy. Int J Radiat Oncol Biol Phys 2006;64:650-656.
25. Arriagada R, Chevalier TL, Quoix E, et al. ASTRO plenary: effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. Int J Radiat Oncol Biol Phys 1991;20:1183-1190.
26. Yamamoto N, Miyamoto T, Nishimura H, et al. Preoperative carbon ion radiotherapy for non-small cell lung cancer with chest wall invasion- pathological findings concerning tumor response and radiation induced lung injury in the resected organs. Lung Cancer 2003;42:87-95.
27. Blancher C, Moor JW, Talks KL, et al. Relationship pf hypoxiainducible factor (HIF)-1 alpha and HIF alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 2000;60:7106-7113.
28. Timmermen R, Papiez L, McCarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-1955.
29. Wulf JW, Haedinger U, Oppitz U, et al. Stereotactic radiotherapy for primary cancer and pulmonary metastasis: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004;60:186-196.
30. Bogart JA. Definitive radiotherapy for stage I non-small cell lung cancer. Ain't nothing like the real thing? J Thorac Oncol 2006;8:763-765.
31. Asamura H. Treatment of choice for stage I non-small cell lung cancer: surgery or radiotherapy? J Thorac Oncol 2006;8:766-767.
32. Harpole DH, Herndon JE, Yung WG, et al. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995;76:787-796.
33. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-129.
34. Graham MV, Purdy JA, Emaimi B, et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999;45:323-329.
35. Kadono K, Homma T, Naitoh A, et al. The effect of heavy ion particle irradiation on lung function in patients with stage I non-small cell lung cancers. Chest 2002;122:1925-1932.
36. Miyamoto T. Carbon beam radiotherapy. Jpn J Lung Cancer 2004;44:741-751.